An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

NCT ID: NCT00809965

Last Updated: 2014-09-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

15526 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients with a recent acute coronary syndrome compared with placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute coronary syndrome (ACS) is a serious and life threatening condition. Following an acute coronary syndrome event patients are at risk of important additional clinical events such as death, myocardial infarction, and stroke. Six months after patients present with an index event of ST-segment myocardial infarction, approximately 15% will either have died or had another episode of myocardial ischemia, and a similar situation exists for non-ST-segment elevation myocardial infarction/unstable angina patients. This randomized; double-blind; placebo controlled study will evaluate the efficacy and safety of rivaroxaban in addition to standard care in patients with a recent ACS. Patients will be given rivaroxaban (2.5 mg twice daily or 5 mg twice daily) or placebo (twice daily) in addition to standard care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Myocardial Infarction Myocardial Ischemia Unstable Angina

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rivaroxaban 2.5 mg bid

One 2.5 mg rivaroxaban tablet twice daily for up to 6 months

Group Type EXPERIMENTAL

Rivaroxaban 2.5 mg

Intervention Type DRUG

One tablet twice daily

Standard of care

Intervention Type DRUG

Rivaroxaban 5 mg bid

One 5 mg rivaroxaban tablet twice daily for up to 6 months

Group Type EXPERIMENTAL

Rivaroxaban 5 mg

Intervention Type DRUG

One tablet twice daily

Standard of care

Intervention Type DRUG

Placebo

One placebo tablet twice daily for up to 6 months

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

One placebo tablet twice daily

Standard of care

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rivaroxaban 2.5 mg

One tablet twice daily

Intervention Type DRUG

Rivaroxaban 5 mg

One tablet twice daily

Intervention Type DRUG

Placebo

One placebo tablet twice daily

Intervention Type DRUG

Standard of care

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must be currently receiving aspirin therapy alone or in combination with a thienopyridine per national or local dosing recommendation
* Have been hospitalized for symptoms suggestive of acute coronary syndrome that lasted at least 10 minutes at rest and occurred 48 hours or less before going to the hospital

Exclusion Criteria

* Any condition that, in the opinion of the investigator, contraindicates anticoagulant therapy or would have an unacceptable risk of bleeding
* Need for continued anticoagulant therapy
* Significant renal impairment or known significant liver disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bayer

INDUSTRY

Sponsor Role collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial

Role: STUDY_DIRECTOR

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham, Alabama, United States

Site Status

Geneva, Alabama, United States

Site Status

Mobile, Alabama, United States

Site Status

Anaheim, California, United States

Site Status

Burbank, California, United States

Site Status

Los Angeles, California, United States

Site Status

Mission Hills, California, United States

Site Status

San Diego, California, United States

Site Status

Aurora, Colorado, United States

Site Status

Littleton, Colorado, United States

Site Status

Jacksonville, Florida, United States

Site Status

Jupiter, Florida, United States

Site Status

Kissimmee, Florida, United States

Site Status

Miami, Florida, United States

Site Status

Ocala, Florida, United States

Site Status

Orlando, Florida, United States

Site Status

Ormond Beach, Florida, United States

Site Status

St. Petersburg, Florida, United States

Site Status

Columbus, Georgia, United States

Site Status

Rome, Georgia, United States

Site Status

Aurora, Illinois, United States

Site Status

Indianapolis, Indiana, United States

Site Status

Merrillville, Indiana, United States

Site Status

Munster, Indiana, United States

Site Status

Valparaiso, Indiana, United States

Site Status

Overland Park, Kansas, United States

Site Status

Wichita, Kansas, United States

Site Status

Lacombe, Louisiana, United States

Site Status

Bethesda, Maryland, United States

Site Status

Boston, Massachusetts, United States

Site Status

Flint, Michigan, United States

Site Status

Grand Blanc, Michigan, United States

Site Status

Grand Rapids, Michigan, United States

Site Status

Kalamazoo, Michigan, United States

Site Status

Mount Clemens, Michigan, United States

Site Status

Petoskey, Michigan, United States

Site Status

Tupelo, Mississippi, United States

Site Status

St Louis, Missouri, United States

Site Status

Kalispell, Montana, United States

Site Status

Bridgewater, New Jersey, United States

Site Status

Linden, New Jersey, United States

Site Status

Buffalo, New York, United States

Site Status

Cortlandt Manor, New York, United States

Site Status

Saratoga Springs, New York, United States

Site Status

Stony Brook, New York, United States

Site Status

Syracuse, New York, United States

Site Status

Winston-Salem, North Carolina, United States

Site Status

Cincinnati, Ohio, United States

Site Status

Cleveland, Ohio, United States

Site Status

Columbus, Ohio, United States

Site Status

Dayton, Ohio, United States

Site Status

Fairview Park, Ohio, United States

Site Status

Bartlesville, Oklahoma, United States

Site Status

Oklahoma City, Oklahoma, United States

Site Status

Doylestown, Pennsylvania, United States

Site Status

Langhorne, Pennsylvania, United States

Site Status

Ridley Park, Pennsylvania, United States

Site Status

Sayre, Pennsylvania, United States

Site Status

West Chester, Pennsylvania, United States

Site Status

York, Pennsylvania, United States

Site Status

Greenville, South Carolina, United States

Site Status

Johnson City, Tennessee, United States

Site Status

Memphis, Tennessee, United States

Site Status

Amarillo, Texas, United States

Site Status

Lubbock, Texas, United States

Site Status

Odessa, Texas, United States

Site Status

Tomball, Texas, United States

Site Status

Salt Lake City, Utah, United States

Site Status

Burlington, Vermont, United States

Site Status

Danville, Virginia, United States

Site Status

Roanoke, Virginia, United States

Site Status

Spokane, Washington, United States

Site Status

Wausau, Wisconsin, United States

Site Status

Buenos Aires, , Argentina

Site Status

Corrientes, , Argentina

Site Status

Córdoba, , Argentina

Site Status

Junín, , Argentina

Site Status

La Plata, , Argentina

Site Status

Mar del Plata, , Argentina

Site Status

Morón, , Argentina

Site Status

Resistencia, , Argentina

Site Status

Rosario, , Argentina

Site Status

Salta, , Argentina

Site Status

San Luis, , Argentina

Site Status

San Miguel de Tucumán, , Argentina

Site Status

Santa Fe, , Argentina

Site Status

Bedford Park, , Australia

Site Status

Chermside, , Australia

Site Status

Coffs Harbour South, , Australia

Site Status

Douglas, , Australia

Site Status

Epping, , Australia

Site Status

Fremantle, , Australia

Site Status

Heidelberg, , Australia

Site Status

Herston, , Australia

Site Status

Launceston, , Australia

Site Status

Milton, , Australia

Site Status

Newcastle, , Australia

Site Status

Parkville, , Australia

Site Status

Perth, , Australia

Site Status

Southport, , Australia

Site Status

Woolloongabba, , Australia

Site Status

Bonheiden, , Belgium

Site Status

Brussels, , Belgium

Site Status

Eupen, , Belgium

Site Status

Genk, , Belgium

Site Status

Huy, , Belgium

Site Status

Leuven, , Belgium

Site Status

Mol, , Belgium

Site Status

Tienen, , Belgium

Site Status

Belo Horizonte, , Brazil

Site Status

Blumenau, , Brazil

Site Status

Campina Grande do Sul, , Brazil

Site Status

Campinas, , Brazil

Site Status

Curitiba, , Brazil

Site Status

Porto Alegre, , Brazil

Site Status

Recife, , Brazil

Site Status

Ribeirão Preto, , Brazil

Site Status

Rio de Janeiro, , Brazil

Site Status

Salvador, , Brazil

Site Status

São José do Rio Preto, , Brazil

Site Status

São Paulo, , Brazil

Site Status

Burgas, , Bulgaria

Site Status

Dimitrovgrad, , Bulgaria

Site Status

Haskovo, , Bulgaria

Site Status

Pazardzhik, , Bulgaria

Site Status

Pleven, , Bulgaria

Site Status

Plovdiv, , Bulgaria

Site Status

Rousse, , Bulgaria

Site Status

Sevlievo, , Bulgaria

Site Status

Sofia, , Bulgaria

Site Status

Varna, , Bulgaria

Site Status

Veliko Tarnovo, , Bulgaria

Site Status

Edmonton, Alberta, Canada

Site Status

Kelowna, British Columbia, Canada

Site Status

Maple Ridge, British Columbia, Canada

Site Status

Victoria, British Columbia, Canada

Site Status

St. John's, Newfoundland and Labrador, Canada

Site Status

Greater Sudbury, Ontario, Canada

Site Status

London, Ontario, Canada

Site Status

Newmarket, Ontario, Canada

Site Status

Oshawa, Ontario, Canada

Site Status

Ottawa, Ontario, Canada

Site Status

Granby, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Québec, Quebec, Canada

Site Status

Saint-Charles-Borromée, Quebec, Canada

Site Status

Saint-Georges, Quebec, Canada

Site Status

Sherbrooke, Quebec, Canada

Site Status

Ste-Foy, Quebec, Canada

Site Status

North Battleford, Saskatchewan, Canada

Site Status

Laval, , Canada

Site Status

Antofagasta, , Chile

Site Status

Chile, , Chile

Site Status

Osorno X Región, , Chile

Site Status

Punta Arenas, , Chile

Site Status

San Bernardo, , Chile

Site Status

Santiago, , Chile

Site Status

Santiago Rm, , Chile

Site Status

Talcahuano, , Chile

Site Status

Temuco, , Chile

Site Status

Valdivia X Región, , Chile

Site Status

Victoria, , Chile

Site Status

Viña del Mar, , Chile

Site Status

Beijing, , China

Site Status

Beijing Prc, , China

Site Status

Changsha, , China

Site Status

Daqing, , China

Site Status

Guangzhou, , China

Site Status

Hangzhou, , China

Site Status

Harbin, , China

Site Status

Jinan, , China

Site Status

Nanjing, , China

Site Status

Shanghai, , China

Site Status

Shenyang, , China

Site Status

Tianjin, , China

Site Status

Xi'an, , China

Site Status

Armenia, , Colombia

Site Status

Barranquilla, , Colombia

Site Status

Bogotá Dc, , Colombia

Site Status

Cali Valle Del Cauca, , Colombia

Site Status

Envigado, , Colombia

Site Status

Manizales, , Colombia

Site Status

Medellín, , Colombia

Site Status

Santander, , Colombia

Site Status

Rijeka, , Croatia

Site Status

Slavonski Brod, , Croatia

Site Status

Suska 6, , Croatia

Site Status

Benešov nad Černou, , Czechia

Site Status

Brno, , Czechia

Site Status

České Budějovice, , Czechia

Site Status

Český Krumlov, , Czechia

Site Status

Hradec Králové, , Czechia

Site Status

Kolín, , Czechia

Site Status

Kroměříž, , Czechia

Site Status

Litomyšl, , Czechia

Site Status

Náchod, , Czechia

Site Status

Pardubice, , Czechia

Site Status

Plzeò 1, , Czechia

Site Status

Poruba, , Czechia

Site Status

Prague, , Czechia

Site Status

Praha 10 N/A, , Czechia

Site Status

Slaný, , Czechia

Site Status

Teplice, , Czechia

Site Status

Ústí nad Labem, , Czechia

Site Status

Znojmo, , Czechia

Site Status

Aalborg, , Denmark

Site Status

Copenhagen, , Denmark

Site Status

Esbjerg, , Denmark

Site Status

Holbæk, , Denmark

Site Status

Horsens, , Denmark

Site Status

Kolding, , Denmark

Site Status

Odense, , Denmark

Site Status

Alexandria, , Egypt

Site Status

Cairo, , Egypt

Site Status

Ismailia, , Egypt

Site Status

Menofeya, , Egypt

Site Status

Besançon, , France

Site Status

Cannes, , France

Site Status

Chambray-lès-Tours, , France

Site Status

Chartres, , France

Site Status

Créteil, , France

Site Status

Dijon, , France

Site Status

Haguenau, , France

Site Status

Lagny, , France

Site Status

Marseille, , France

Site Status

Montfermeil, , France

Site Status

Paris, , France

Site Status

Poitiers, , France

Site Status

Bad Friedrichshall, , Germany

Site Status

Berlin, , Germany

Site Status

Bonn, , Germany

Site Status

Dresden, , Germany

Site Status

Essen, , Germany

Site Status

Esslingen am Neckar, , Germany

Site Status

Frankfurt am Main, , Germany

Site Status

Freiburg im Breisgau, , Germany

Site Status

Göttingen, , Germany

Site Status

Greifswald, , Germany

Site Status

Halle, , Germany

Site Status

Hamburg, , Germany

Site Status

Hanover, , Germany

Site Status

Heidelberg, , Germany

Site Status

Kiel, , Germany

Site Status

Leipzig, , Germany

Site Status

Limburg, , Germany

Site Status

Lübeck, , Germany

Site Status

Magdeburg, , Germany

Site Status

Mannheim, , Germany

Site Status

Weiden, , Germany

Site Status

Wermsdorf, , Germany

Site Status

Witten, , Germany

Site Status

Athens, , Greece

Site Status

Larissa, , Greece

Site Status

Rhodes, , Greece

Site Status

Thessalonikis, , Greece

Site Status

Budapest, , Hungary

Site Status

Debrecen, , Hungary

Site Status

Győr, , Hungary

Site Status

Kecskemét, , Hungary

Site Status

Komárom, , Hungary

Site Status

Miskolc, , Hungary

Site Status

Szolnok, , Hungary

Site Status

Szombathely, , Hungary

Site Status

Zalaegerszeg, , Hungary

Site Status

Ahmedabad, , India

Site Status

Allahābād, , India

Site Status

Bangalore, , India

Site Status

Chandigarh, , India

Site Status

Chennai, , India

Site Status

Coimbatore, , India

Site Status

Ernākulam, , India

Site Status

Gandhinagar Guiarat, , India

Site Status

Gurgaon, , India

Site Status

Hyderabad, , India

Site Status

Jaipur, , India

Site Status

Karamsad, , India

Site Status

Kochi, , India

Site Status

Kolkata, , India

Site Status

Lucknow Gpo, , India

Site Status

Ludhiana, , India

Site Status

Madurai, , India

Site Status

Mangalore, , India

Site Status

Mumbai, , India

Site Status

Mysore, , India

Site Status

Nagpur, , India

Site Status

Nashik, , India

Site Status

New Delhi, , India

Site Status

Pune, , India

Site Status

Surat, , India

Site Status

Trissur, , India

Site Status

Trivandrum, , India

Site Status

Vadodara, , India

Site Status

Vijayawada, , India

Site Status

Afula, , Israel

Site Status

Hadera, , Israel

Site Status

Haifa, , Israel

Site Status

Jerusalem, , Israel

Site Status

Nahariya, , Israel

Site Status

Petah Tikva, , Israel

Site Status

Rehovot, , Israel

Site Status

Safed, , Israel

Site Status

Tel Aviv, , Israel

Site Status

Tiberias, , Israel

Site Status

Anan, , Japan

Site Status

Fukui, , Japan

Site Status

Fukuoka, , Japan

Site Status

Fukuyama, , Japan

Site Status

Gifu, , Japan

Site Status

Higashiosaka, , Japan

Site Status

Kagoshima, , Japan

Site Status

Kanazawa, , Japan

Site Status

Kasuga, , Japan

Site Status

Kawachi-Nagano, , Japan

Site Status

Kawasaki, , Japan

Site Status

Kisarazu, , Japan

Site Status

Kobe, , Japan

Site Status

Kumamoto, , Japan

Site Status

Kuwana, , Japan

Site Status

Maebashi-City Gunma, , Japan

Site Status

Matsudo, , Japan

Site Status

Matsumoto, , Japan

Site Status

Matsuyama-City Ehime, , Japan

Site Status

Miyazaki-Gun, , Japan

Site Status

Nagano, , Japan

Site Status

Nagasaki, , Japan

Site Status

Nagoya, , Japan

Site Status

Namegata, , Japan

Site Status

Nankoku, , Japan

Site Status

Nishinomiya, , Japan

Site Status

Okayama, , Japan

Site Status

Osaka, , Japan

Site Status

Sakaidechō, , Japan

Site Status

Sakura-Shi, , Japan

Site Status

Suwa, , Japan

Site Status

Tokushima, , Japan

Site Status

Tokyo, , Japan

Site Status

Toyama, , Japan

Site Status

Urasoe, , Japan

Site Status

Yamaguchi, , Japan

Site Status

Yokohama, , Japan

Site Status

Yonago-Shi, , Japan

Site Status

Daugavpils, , Latvia

Site Status

Liepāja, , Latvia

Site Status

Riga, , Latvia

Site Status

Kaunas, , Lithuania

Site Status

Klaipėda, , Lithuania

Site Status

Šiauliai, , Lithuania

Site Status

Vilnius, , Lithuania

Site Status

Vilnius Lt, , Lithuania

Site Status

Johor Bahru, , Malaysia

Site Status

Kelantan, , Malaysia

Site Status

Kota Samarahan, , Malaysia

Site Status

Kuala Lumpur, , Malaysia

Site Status

Selayang Baru Utara, , Malaysia

Site Status

Aguascalientes, , Mexico

Site Status

Cd. Juarez, , Mexico

Site Status

Culiacán, , Mexico

Site Status

Guadalajara, , Mexico

Site Status

León, , Mexico

Site Status

Mexico City, , Mexico

Site Status

México, , Mexico

Site Status

Monterrey, , Mexico

Site Status

Querétaro, , Mexico

Site Status

San Luis Potosí City, , Mexico

Site Status

Sinaloa, , Mexico

Site Status

Veracruz, , Mexico

Site Status

Zapopan, , Mexico

Site Status

Marrakesh, , Morocco

Site Status

Meknes, , Morocco

Site Status

Rabat, , Morocco

Site Status

Amsterdam, , Netherlands

Site Status

Arnhem, , Netherlands

Site Status

Delft, , Netherlands

Site Status

Eindhoven, , Netherlands

Site Status

Gorinchem, , Netherlands

Site Status

Gouda, , Netherlands

Site Status

Haarlem, , Netherlands

Site Status

Harderwijk, , Netherlands

Site Status

Hengelo Ov, , Netherlands

Site Status

Nieuwegein, , Netherlands

Site Status

Nijmegen, , Netherlands

Site Status

Sittard, , Netherlands

Site Status

The Hague, , Netherlands

Site Status

Vlaardingen, , Netherlands

Site Status

Auckland, , New Zealand

Site Status

Dunedin, , New Zealand

Site Status

Hamilton, , New Zealand

Site Status

Lower Hutt, , New Zealand

Site Status

Nelson, , New Zealand

Site Status

New Plymouth, , New Zealand

Site Status

Iloilo City, , Philippines

Site Status

Marikina City, , Philippines

Site Status

Quezon City, , Philippines

Site Status

Będzin, , Poland

Site Status

Bialystok, , Poland

Site Status

Bielsko-Biala, , Poland

Site Status

Bydgoszcz, , Poland

Site Status

Bytom, , Poland

Site Status

Dąbrowa Górnicza, , Poland

Site Status

Gdynia, , Poland

Site Status

Gorlice, , Poland

Site Status

Katowice, , Poland

Site Status

Katowice-Ochojec, , Poland

Site Status

Koszalin, , Poland

Site Status

Krakow, , Poland

Site Status

Kutno, , Poland

Site Status

Lodz, , Poland

Site Status

Nowy Targ, , Poland

Site Status

Opole, , Poland

Site Status

Poznan, , Poland

Site Status

Płock, , Poland

Site Status

Ruda Śląska, , Poland

Site Status

Starogard Gdanski Nap, , Poland

Site Status

Szczecin, , Poland

Site Status

Torun, , Poland

Site Status

Warsaw, , Poland

Site Status

Wroclaw, , Poland

Site Status

Włocławek, , Poland

Site Status

Zamość, , Poland

Site Status

Aveiro, , Portugal

Site Status

Braga, , Portugal

Site Status

Coimbra, , Portugal

Site Status

Faro, , Portugal

Site Status

Leiria, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Penafiel, , Portugal

Site Status

Porto, , Portugal

Site Status

Vila Nova de Gaia, , Portugal

Site Status

Bucharest, , Romania

Site Status

Craiova, , Romania

Site Status

Focşani, , Romania

Site Status

Oradea, , Romania

Site Status

Piteşti, , Romania

Site Status

Tg Mures, , Romania

Site Status

Timișoara, , Romania

Site Status

Arkhangelsk, , Russia

Site Status

Barnaul, , Russia

Site Status

Chelyabinsk, , Russia

Site Status

Ivanovo, , Russia

Site Status

Kaliningrad, , Russia

Site Status

Kemerovo, , Russia

Site Status

Kirov, , Russia

Site Status

Krasnodar, , Russia

Site Status

Krasnoyarsk, , Russia

Site Status

Kursk, , Russia

Site Status

Lyubertsy, , Russia

Site Status

Moscow, , Russia

Site Status

Nizhny Novgorod, , Russia

Site Status

Novosibirsk, , Russia

Site Status

Omsk, , Russia

Site Status

Orenburg, , Russia

Site Status

Penza, , Russia

Site Status

Perm, , Russia

Site Status

Pskov, , Russia

Site Status

Pushkin, Saint-Petersburg, , Russia

Site Status

Ryazan, , Russia

Site Status

Saint Petersburg, , Russia

Site Status

Saint-Petersbrug, , Russia

Site Status

Sestroretsk, Saint-Petersburg, , Russia

Site Status

Syktyvkar, , Russia

Site Status

Tomsk, , Russia

Site Status

Tula, , Russia

Site Status

Tumen Region, , Russia

Site Status

Vladimir, , Russia

Site Status

Voronezh, , Russia

Site Status

Yaroslavl Nap, , Russia

Site Status

Yekaterinburg, , Russia

Site Status

Belgrade, , Serbia

Site Status

Kragujevac, , Serbia

Site Status

Niš, , Serbia

Site Status

Niška Banja, , Serbia

Site Status

Bratislava, , Slovakia

Site Status

Nové Zámky, , Slovakia

Site Status

Žilina, , Slovakia

Site Status

Daejeon, , South Korea

Site Status

Gwangju, , South Korea

Site Status

Seognam-Si, Kyungki-Do, , South Korea

Site Status

Seoul, , South Korea

Site Status

Suwon, , South Korea

Site Status

Alicante, , Spain

Site Status

Aviles Asturias, , Spain

Site Status

Barcelona, , Spain

Site Status

Burgos, , Spain

Site Status

Elche, , Spain

Site Status

Figueres, , Spain

Site Status

Guadalajara, , Spain

Site Status

Huelva, , Spain

Site Status

Madrid, , Spain

Site Status

Málaga, , Spain

Site Status

Salamanca, , Spain

Site Status

Santander, , Spain

Site Status

Seville, , Spain

Site Status

Tarragona, , Spain

Site Status

Valencia, , Spain

Site Status

Vigo, , Spain

Site Status

Danderyd, , Sweden

Site Status

Gothenburg, , Sweden

Site Status

Jönköping, , Sweden

Site Status

Linköping, , Sweden

Site Status

Lund, , Sweden

Site Status

Malmo, , Sweden

Site Status

Örebro, , Sweden

Site Status

Östersund, , Sweden

Site Status

Umeå, , Sweden

Site Status

Bangkok, , Thailand

Site Status

Chiang Mai, , Thailand

Site Status

Pathum Thani, , Thailand

Site Status

Phathumwan, , Thailand

Site Status

Sfax, , Tunisia

Site Status

Sousse, , Tunisia

Site Status

Tunis, , Tunisia

Site Status

Ankara, , Turkey (Türkiye)

Site Status

Aydin, , Turkey (Türkiye)

Site Status

Bursa, , Turkey (Türkiye)

Site Status

Erzurum, , Turkey (Türkiye)

Site Status

Istanbul, , Turkey (Türkiye)

Site Status

Izmir, , Turkey (Türkiye)

Site Status

Kayseri, , Turkey (Türkiye)

Site Status

Samsun, , Turkey (Türkiye)

Site Status

Sivas, , Turkey (Türkiye)

Site Status

Cherkassy, , Ukraine

Site Status

Dnipro, , Ukraine

Site Status

Donetsk, , Ukraine

Site Status

Ivano-Frankivsk, , Ukraine

Site Status

Kharkiv, , Ukraine

Site Status

Khemelnitskiy, , Ukraine

Site Status

Kiev, , Ukraine

Site Status

Luhansk, , Ukraine

Site Status

Lutsk, , Ukraine

Site Status

Lviv, , Ukraine

Site Status

Mykolayiv, , Ukraine

Site Status

Poltava, , Ukraine

Site Status

Sumy, , Ukraine

Site Status

Ternopil, , Ukraine

Site Status

Uzhhorod, , Ukraine

Site Status

Vinnitsa, , Ukraine

Site Status

Zaporizhzhya, , Ukraine

Site Status

Zhytomyr, , Ukraine

Site Status

Birmingham, , United Kingdom

Site Status

Blackpool, , United Kingdom

Site Status

Bristol, , United Kingdom

Site Status

Chertsey, , United Kingdom

Site Status

Chesterfield, , United Kingdom

Site Status

East Sussex, , United Kingdom

Site Status

Exeter, , United Kingdom

Site Status

Hampshire, , United Kingdom

Site Status

Harrow, , United Kingdom

Site Status

Hull, , United Kingdom

Site Status

Leicester, , United Kingdom

Site Status

Lincoln, , United Kingdom

Site Status

Manchester, , United Kingdom

Site Status

Middlesbrough, , United Kingdom

Site Status

Portadown, , United Kingdom

Site Status

Stockport, , United Kingdom

Site Status

Warwick, , United Kingdom

Site Status

Worcester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Brazil Bulgaria Canada Chile China Colombia Croatia Czechia Denmark Egypt France Germany Greece Hungary India Israel Japan Latvia Lithuania Malaysia Mexico Morocco Netherlands New Zealand Philippines Poland Portugal Romania Russia Serbia Slovakia South Korea Spain Sweden Thailand Tunisia Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Chi G, AlKhalfan F, Lee JJ, Montazerin SM, Fitzgerald C, Korjian S, Omar W, Barnathan E, Plotnikov A, Gibson CM. Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial. Front Cardiovasc Med. 2024 Jan 8;10:1269011. doi: 10.3389/fcvm.2023.1269011. eCollection 2023.

Reference Type DERIVED
PMID: 38259304 (View on PubMed)

Gibson WJ, Nafee T, Travis R, Yee M, Kerneis M, Ohman M, Gibson CM. Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis. J Thromb Thrombolysis. 2020 Jan;49(1):1-9. doi: 10.1007/s11239-019-01940-8.

Reference Type DERIVED
PMID: 31535314 (View on PubMed)

Gibson CM, Levitan B, Gibson WJ, Yee MK, Murphy SA, Yuan Z, Chakrabarti AK, Lee M, Braunwald E. Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome. J Am Coll Cardiol. 2018 Jul 10;72(2):129-136. doi: 10.1016/j.jacc.2018.04.055.

Reference Type DERIVED
PMID: 29976285 (View on PubMed)

Cavender MA, Gibson CM, Braunwald E, Wiviott SD, Murphy SA, Toda Kato E, Plotnikov AN, Amuchastegui M, Oude Ophuis T, van Hessen M, Mega JL. The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial. Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):468-74. doi: 10.1177/2048872614554109. Epub 2014 Oct 15.

Reference Type DERIVED
PMID: 25318481 (View on PubMed)

Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E; ATLAS-ACS 2 TIMI 51 Investigators. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. J Am Coll Cardiol. 2013 Jul 23;62(4):286-90. doi: 10.1016/j.jacc.2013.03.041. Epub 2013 Apr 16.

Reference Type DERIVED
PMID: 23602776 (View on PubMed)

Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). J Am Coll Cardiol. 2013 May 7;61(18):1853-9. doi: 10.1016/j.jacc.2013.01.066. Epub 2013 Mar 7.

Reference Type DERIVED
PMID: 23500262 (View on PubMed)

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

Reference Type DERIVED
PMID: 22077192 (View on PubMed)

Gibson CM, Mega JL, Burton P, Goto S, Verheugt F, Bode C, Plotnikov A, Sun X, Cook-Bruns N, Braunwald E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome. Am Heart J. 2011 May;161(5):815-821.e6. doi: 10.1016/j.ahj.2011.01.026.

Reference Type DERIVED
PMID: 21570509 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RIVAROXACS3001

Identifier Type: OTHER

Identifier Source: secondary_id

CR014710

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evolocumab in STEMI
NCT06081803 ACTIVE_NOT_RECRUITING PHASE3